FDA Device Recalls

Recalls /

#154696

Product

AQUIOS CL Flow Cytometer, Ref no. B30166, Software Versions 2.0 and 2.0.1 Product Usage: The AQUIOS CL Flow Cytometer is intended for use with in vitro diagnostic flow cytometric applications using up to four fluorescent detection channels using a blue (488 nm) laser, two light scatter detection channels and electronic volume (EV).

FDA product code
OYEFlow Cytometric Reagents And Accessories.
Device class
Class 2
Medical specialty
Hematology
510(k) numbers
K141932
Affected lot / code info
All

Why it was recalled

Beckman Coulter has confirmed that the Export feature located in the Results area of the AQUIOS System software is not correctly exporting Tetra Combo CRD files.

Root cause (FDA determination)

Other

Action the firm took

An Urgent Medical Device Recall letter was sent on 4/3/17 to inform customers that area of the AQUIOS System software is not correctly exporting Tetra Combo CRD files. The letter informs the customers of the impact, action, and resolution. Customers are instructed to complete and return the enclosed response form within 10 days. Customers with questions are instructed to contact Customer Support Center via website, http://www.beckmancoulter.com/customersupport/support, Via phone, call 1-800-369-0333 in the US. Customers outside the US are instructed to contact their local Beckman Coulter Representative.

Recalling firm

Firm
Beckman Coulter Inc.
Address
250 S Kraemer Blvd, Brea, California 92821-6232

Distribution

Distribution pattern
Worldwide - US Nationwide in the countries of: Angola, Australia, Belgium, Botswana, Canada, Chile, Columbia, Czech Republic, Denmark, Finland, France, Germany, Ghana, Israel, Italy, Malaysia, Nambia, Netherlands, Pakistan, Panama, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, Uganda, United Kingdom and Zambia

Timeline

Recall initiated
2017-04-03
Posted by FDA
2017-04-17
Terminated
2017-08-07
Status

Source: openFDA Device Recall endpoint. Recall record ID #154696. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.